Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Genetic Analysis

0.69 NOK

+4.55 %

Less than 1K followers

GEAN

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Genetic Analysis

20212022202320242025
Revenue6.811.214.215.916.7
growth-%64.1 %26.8 %12.3 %5.2 %
EBITDA-24.353.8-18.2-9.5-6.1
EBIT-28.9-28.2-23.8-14.2-11.3
Profit before taxes-29.0-28.3-23.8-14.8-11.4
Net income-29.0-28.3-23.8-14.8-11.4
EPS-1.16-1.13-0.62-0.34-0.18
Dividend0.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

20212022202320242025
EBITDA-%-357.9 %481.8 %-128.9 %-60.0 %-36.4 %
EBIT-%-424.6 %-252.5 %-168.3 %-89.5 %-67.4 %
ROE-40.2 %-64.0 %-74.5 %-65.7 %-42.1 %
ROI-34.7 %-43.9 %-44.5 %-34.9 %-21.8 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.